Forward Management LLC Buys 215 Shares of Core Laboratories N.V. (CLB)
Forward Management LLC increased its position in shares of Core Laboratories N.V. (NYSE:CLB) by 6.4% during the second quarter, Holdings Channel reports. The firm owned 3,569 shares of the oil and gas company’s stock after buying an additional 215 shares during the period. Forward Management LLC’s holdings in Core Laboratories N.V. were worth $361,000 as of its most recent filing with the SEC.
Several other large investors also recently added to or reduced their stakes in CLB. Parallel Advisors LLC raised its stake in Core Laboratories N.V. by 33.4% in the first quarter. Parallel Advisors LLC now owns 891 shares of the oil and gas company’s stock worth $101,000 after buying an additional 223 shares during the period. Quantbot Technologies LP acquired a new position in shares of Core Laboratories N.V. during the first quarter worth about $106,000. Advisory Services Network LLC acquired a new position in shares of Core Laboratories N.V. during the first quarter worth about $118,000. FNY Managed Accounts LLC acquired a new position in shares of Core Laboratories N.V. during the first quarter worth about $123,000. Finally, Shine Investment Advisory Services Inc. acquired a new position in shares of Core Laboratories N.V. during the second quarter worth about $134,000.
Core Laboratories N.V. (CLB) opened at 92.92 on Friday. The firm’s 50 day moving average price is $101.46 and its 200-day moving average price is $108.84. Core Laboratories N.V. has a 12-month low of $92.81 and a 12-month high of $125.83. The stock has a market cap of $4.10 billion, a P/E ratio of 57.01 and a beta of 1.60.
Core Laboratories N.V. (NYSE:CLB) last posted its quarterly earnings results on Monday, July 24th. The oil and gas company reported $0.52 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.51 by $0.01. Core Laboratories N.V. had a net margin of 11.80% and a return on equity of 49.29%. The firm had revenue of $163.90 million during the quarter, compared to the consensus estimate of $168.23 million. During the same quarter in the previous year, the firm posted $0.35 earnings per share. The company’s revenue was up 10.7% on a year-over-year basis. Equities research analysts anticipate that Core Laboratories N.V. will post $2.09 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Monday, August 14th. Stockholders of record on Monday, July 17th will be paid a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a dividend yield of 2.37%. The ex-dividend date is Thursday, July 13th. Core Laboratories N.V.’s dividend payout ratio is presently 134.15%.
ILLEGAL ACTIVITY NOTICE: This article was originally published by Daily Political and is the property of of Daily Political. If you are reading this article on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright law. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/08/12/forward-management-llc-buys-215-shares-of-core-laboratories-n-v-clb.html.
CLB has been the topic of a number of research analyst reports. Royal Bank Of Canada set a $145.00 price target on Core Laboratories N.V. and gave the company a “buy” rating in a report on Saturday, June 17th. Zacks Investment Research upgraded Core Laboratories N.V. from a “hold” rating to a “buy” rating and set a $116.00 price target on the stock in a report on Monday, June 12th. Loop Capital upgraded Core Laboratories N.V. from a “hold” rating to a “buy” rating and boosted their price target for the company from $125.00 to $130.00 in a report on Friday, April 21st. BidaskClub upgraded Core Laboratories N.V. from a “sell” rating to a “hold” rating in a report on Wednesday, July 5th. Finally, Scotiabank set a $136.00 price target on Core Laboratories N.V. and gave the company a “hold” rating in a report on Saturday, April 22nd. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and four have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $117.17.
About Core Laboratories N.V.
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.
Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories N.V. (NYSE:CLB).
Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with MarketBeat.com's FREE daily email newsletter.